Finance

Lists
INTI:OTCMKTS
Inhibitor Therapeutics Inc
0,098 $
0,00%
(0,00) 1D
2 հոկ, 15:16:24 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTI...
Mkt. cap
17,03 մլն
Avg. vol.
408,00
Volume
0,00
52-wk high
0,12 $
52-wk low
0,04 $
EPS
-0,02 $
Beta
-0,44
Shares outstanding
173,79 մլն
No. of employees
5
Mkt. cap
17,03 մլն
Avg. vol.
408,00
Volume
0,00
52-wk high
0,12 $
52-wk low
0,04 $
EPS
-0,02 $
Beta
-0,44
Shares outstanding
173,79 մլն
No. of employees
5
News stories
From web sources and news partners
About Inhibitor Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersՏամպա, Ֆլորիդա, Միացյալ Նահանգներ
Sector-
Websiteinhibitortx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
377,79 հզր
757,25 հզր
340,56 հզր
223,56 հզր
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
363,43 հզր
557,87 հզր
355,07 հզր
395,03 հզր
Operating expense
741,22 հզր
1,32 մլն
695,63 հզր
618,60 հզր
Total operating expenses
741,22 հզր
1,32 մլն
695,63 հզր
618,60 հզր
Operating income
-741,22 հզր
-1,32 մլն
-695,63 հզր
-618,60 հզր
Other non operating income
-
-
-
-
EBT including unusual items
-712,18 հզր
-1,30 մլն
-686,42 հզր
-613,93 հզր
EBT excluding unusual items
-712,18 հզր
-1,30 մլն
-686,42 հզր
-613,93 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-712,18 հզր
-1,30 մլն
-686,42 հզր
-613,93 հզր
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
29,03 հզր
19,75 հզր
9,21 հզր
4,66 հզր
Interest expense
-
-
-
-
Net interest expenses
29,03 հզր
19,75 հզր
9,21 հզր
4,66 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps